In last trading session, Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) saw 0.38 million shares changing hands with its beta currently measuring 1.41. Company’s recent per share price level of $3.53 trading at $0.45 or 14.61% at ring of the bell on the day assigns it a market valuation of $5.70M. That closing price of SNOA’s stock is at a discount of -165.44% from its 52-week high price of $9.37 and is indicating a premium of 46.18% from its 52-week low price of $1.90. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 9.16 million shares which gives us an average trading volume of 1.58 million if we extend that period to 3-months.

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) trade information

Upright in the green during last session for gaining 14.61%, in the last five days SNOA remained trading in the green while hitting it’s week-highest on Tuesday, 03/11/25 when the stock touched $3.53 price level, adding 20.85% to its value on the day. Sonoma Pharmaceuticals Inc’s shares saw a change of 31.23% in year-to-date performance and have moved 77.39% in past 5-day. Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) showed a performance of 38.98% in past 30-days. Number of shares sold short was 9746.0 shares which calculate 0.27 days to cover the short interests.

Sonoma Pharmaceuticals Inc (SNOA) estimates and forecasts

This year revenue growth is estimated to rise 21.48% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 4.44M for the same. And 1 analysts are in estimates of company making revenue of 4.34M in the next quarter. Company posted 3.44M and 3.39M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 47.04% during past 5 years.

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA)’s Major holders

Insiders are in possession of 1.25% of company’s total shares while institution are holding 1.26 percent of that, with stock having share float percentage of 1.27%. Investors also watch the number of corporate investors in a company very closely, which is 1.26% institutions for Sonoma Pharmaceuticals Inc that are currently holding shares of the company. CITADEL ADVISORS LLC is the top institutional holder at SNOA for having 0.2 million shares of worth $41412.0. And as of 2024-06-30, it was holding 1.2504 of the company’s outstanding shares.

The second largest institutional holder is GEODE CAPITAL MANAGEMENT, LLC, which was holding about 86644.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.5551 of outstanding shares, having a total worth of $18385.0.

On the other hand, Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 5.3 shares of worth $18705.0 or 0.33% of the total outstanding shares. The later fund manager was in possession of 2.53 shares on Dec 31, 2024 , making its stake of worth around $8923.0 in the company or a holder of 0.16% of company’s stock.